HOME › DRUGS › RESLIZUMAB
ACTIVE SUBSTANCE / INN

RESLIZUMAB

Brand name(s): CINQAIR, Cinqaero
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA761033
Asthma
ACTIVE SUBSTANCE
Reslizumab
REGULATORS
FDA · EMA
SPONSORS / MAH
TEVA RESPIRATORY LLC, Teva B.V.
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CINQAIRBLA761033TEVA RESPIRATORY LLCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
CinqaeroTeva B.V.Authorised15/08/2016Asthma

FULL INTELLIGENCE ON RESLIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →